Ind-Swift Laboratories is trading at INR 274.10 (+15.54%) today, driven by two key company-specific catalysts. * The company reported significantly improved Q1 FY26 earnings on August 10, 2026, with net income surging to INR 246.84 million from INR 87.75 million in the prior year. * Shareholders also approved the issuance of up to 70 lakh fully convertible warrants worth ₹137.20 crore to promoter-group entities on August 5, 2026, aimed at funding expansion and development initiatives.